Which of the following agents is used for the treatment of Thrombocytopenia secondary to myelosuppressive cancer chemotherapy?
Correct answer : C. Oprelvekin
- Oprelvekin (Interleukin 11) is the only agent approved by the FDA for treatment of thrombocytopenia secondary to myelosuppressive cancer chemotherapy
- Filgrastim (G-CSF) and Sargramostim (GM-SCF) are used in the treatment of neutropenia
- Erythropoietin is used in treatment of anemia